Investig Clin Urol.
2020 Jul;61(4):349-354. 10.4111/icu.2020.61.4.349.
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
- Schmidt S
1 - Kunath F1,2
- Coles B3
- Draeger DL1,4
- Krabbe LM1,5
- Dersch R6
- Kilian S7
- Jensen K7
- Dahm P8,9
- Meerpohl JJ10,11
- Affiliations
-
- 1UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Germany
- 2Department of Urology, University Hospital Erlangen, Erlangen, Germany
- 3Velindre NHS Trust, Cardiff University Library Services, Cardiff, United Kingdom
- 4Department of Urology, University of Rostock, Rostock, Germany
- 5Department of Urology, University of Muenster Medical Center, Muenster, Germany
- 6Clinic of Neurology and Neurophysiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 7Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany
- 8Urology Section, Minneapolis VA Health Care System, Minneapolis, MN, USA
- 9Department of Urology, University of Minnesota, Minneapolis, MN, USA
- 10Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, 11Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany
- KMID: 2503544
- DOI: http://doi.org/10.4111/icu.2020.61.4.349
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Mitomycin C vs. bacillus calmette-guerin: comparison of prophylactic efficacy to high risk superficial bladder tumor
- A comparison of mitomycin C and bacillus calmette-guerin for the prophylaaxis of high risk superficial bladder tumors
- Prophylactic Effect of Mitomycin C and Bacillus Calmette-Guerin in Stage T1 of the Superficial Bladder Cancer
- Tuberculous Prostatic Abscess Following Intravesical Bacillus Calmette-Guerin Instillation
- Prognostic indexes in patients treated with intravesical bacillus calmette-guerin for superficial bladder cancer
